DAFNA Capital Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,204,825	Closed	-$5.37M	–	91
2021 Q1	$5.37M	Buy	+1,204,825	New	+$5.61M	1.28%	22
2015 Q4	–	Sell	-119,319	Closed	-$1.41M	–	82
2015 Q3	$1.41M	Sell	119,319 -3,760	-3%	-$59.8K	1.4%	21
2015 Q2	$2.4M	Hold	123,079	–	–	2.03%	18
2015 Q1	$2.19M	Sell	123,079 -15,310	-11%	-$300K	1.68%	15
2014 Q4	$2.55M	Buy	138,389 +9,545	+7%	+$205K	2.01%	15
2014 Q3	$3.12M	Buy	128,844 +11,000	+9%	+$317K	3.14%	11
2014 Q2	$4.3M	Hold	117,844	–	–	4.08%	10
2014 Q1	$5.4M	Hold	117,844	–	–	4.64%	7
2013 Q4	$4.58M	Hold	117,844	–	–	4.72%	7
2013 Q3	$5.34M	Buy	117,844 +31,033	+36%	+$1.59M	5.83%	2
2013 Q2	$4.26M	Buy	+86,811	New	+$4.61M	6.24%	4